144873-97-2

Basic information

• Product Name: [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID
• Synonyms: [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID
• CAS NO: 144873-97-2
• Molecular Formula: C₂₆H₂₁BN₄O₂
• Molecular Weight: 432.28
• Mol File: 144873-97-2.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID(144873-97-2)
• EPA Substance Registry System: [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID(144873-97-2)

Safety Data

• Hazardous Substances Data: 144873-97-2(Hazardous Substances Data)

Usage

General Description

[2-[1-(triphenylmethyl)-1H-tetrazol-5-yl]phenyl]boronic acid is a chemical compound with the molecular formula C27H23BN4O2. It is commonly used in chemical research and pharmaceutical synthesis as a boronic acid derivative. [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID is a tetrazole-based ligand that contains a boronic acid group, making it useful for its ability to form complexes with other molecules, such as proteins or nucleic acids. It has potential applications in the development of new drugs, particularly as a component in the synthesis of potential pharmaceuticals. Additionally, it has been studied for its potential as a fluorescent probe in bioimaging and as a catalyst in organic synthesis reactions.

Upstream product

• 121-43-7 Trimethyl borate 
• 18039-42-4 5-Phenyl-1H-tetrazole 
• 76-83-5 trityl chloride 
• 100-47-0 benzonitrile 
• 154750-11-5 N-(triphenylmethyl)phenyltetrazole 
• 5419-55-6 Triisopropyl borate 

Downstream Products

• 138402-10-5 trityl irbesartan 
• 781664-81-1 N-[[2'-(1-triphenylmethyltetrazol-5yl)biphenyl-4-yl]methyl]-N-valeryl-L-valine methyl ester 
• 1301768-36-4 C₂₄⁽¹⁴⁾CH₂₈N₆O 
• 1421597-66-1 C₄₉H₄₂N₈O₂ 
• 1421597-65-0 C₄₉H₄₀N₈O 
• 1421597-64-9 C₄₉H₄₀N₈O 
• 1421597-63-8 C₄₉H₄₀N₈O 
• 1421597-62-7 C₅₁H₄₀F₃N₇O 
• 1421597-61-6 C₅₁H₄₃N₇O 
• 1421597-60-5 C₅₀H₄₀FN₇O 
• 1421597-59-2 C₅₁H₄₀F₃N₇O₂ 
• 1421597-58-1 C₅₁H₄₀F₃N₇O 
• 1421597-57-0 C₅₁H₄₀N₈O 
• 1421597-56-9 C₅₁H₄₃N₇O 

Relevant articles and documents

The synthesis of radiolabeled Irbesartan using N,N-dimethyl[ 14C]formamide as a source of carbon-14 isotope

Irbesartan (Avapro) is in clinical use as an antihypertensive drug. It is a nonpeptide angiotensin II receptor antagonist. A radiolabeled version of this drug, intended for use in environmental fate studies, was prepared from N,N-dimethyl[14C]f

DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS

In one aspect, the invention relates to compounds having the formula: wherein: Ar, Z, R3, R4 and R5 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT1 re

PROCESSES FOR THE SYNTHESIS OF 5-PHENYL -1 TRITYL-1H-TETRAZOLE

Provided are processes for the synthesis of 5 -phenyl- 1-trityl-lH-tetrazole, an intermediate useful in the synthesis of irbesartan.